Morning Breakouts

Latest California Healthline Stories

Mylan Hopes To Sell EpiPens Directly To Consumers And Bypass Pharmacies

Bloomberg reports on the company’s plans to expand its market and set up its own distribution network. In other health industry news, Walgreens’ CEO talks to analysts about plans for the merger with Rite Aid, a judge rules against Regeneron Pharmaceuticals and Sanofi on a patent dispute and traders are optimistic about biotech sector.

Trump’s Pick For HHS Draws Democrats’ Scrutiny Over Health Care Stock Trading

Senate Democrats call for a delay in the confirmation hearings for Rep. Tom Price, R-Ga., who has been tapped by President-elect Donald Trump to head the Department of Health and Human Services. Democrats want to investigate trades he made while handling legislation in Congress that could impact the value of those shares.

Obama Calls GOP Plan To Delay Health Law Replacement ‘Reckless’

In a commentary in the New England Journal of Medicine, the president acknowledges that the Affordable Care Act has problems but says if Republicans’ don’t have a firm plan for replacing it when they seek to repeal the law, they could do immense damage to consumers. Meanwhile, Democrats ask their Republican colleagues to compromise on modifying the existing law.

A Hint From GOP Leaders: Replacement Plan May Not Maintain Health Law’s Coverage Expansions

In other news about the ongoing debate about the health law, House Speaker Paul Ryan says that a replacement plan will be completed in 2017. But some Republicans are voicing caution as the financial implications hit home. Ultimately, elements of the law may survive.